Sign In
Buy ARWR
$82.00
+0.180 (+0.220%)
At Close: Jun 22, 2026
Arrowhead Pharmaceuticals Presents New Phase 2 Data of Plozasiran in Patients with Mixed Hyperlipidemia
06:04am, Tuesday, 28'th May 2024
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced results from the Phase 2b double blind, randomized MUIR study of investigational plozasiran
Panagora Asset Management Inc. Decreases Stock Holdings in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
07:14am, Monday, 20'th May 2024
Panagora Asset Management Inc. lessened its holdings in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 58.8% during the 4th quarter, according to its most recent disclosure with
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that new interim clinical data on ARO-RAGE, an investigational RNAi-based medicine for the t
Arrowhead Pharmaceuticals: Focus Turns To Upcoming Pipeline Inflection Point
10:44am, Friday, 17'th May 2024
The latest period was a rollercoaster ride for Arrowhead Pharmaceuticals despite significant fundamental developments. Phase 3 results of plozasiran in FCS patients should lead to Arrowhead finally be
Double-Up Delights: 7 Stocks Poised to Soar 100% by 2025
07:08am, Tuesday, 14'th May 2024
If you're wondering what stocks to buy this month, look no further. Every investor wants their stock picks to double in price.
Arrowhead Pharmaceuticals, Inc. (ARWR) Q2 2024 Earnings Call Transcript
09:23pm, Thursday, 09'th May 2024
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR ) Q2 2024 Earnings Conference Call May 9, 2024 4:30 PM ET Company Participants Vince Anzalone - VP, IR Chris Anzalone - President and CEO Bruce Given - Chi
Arrowhead Pharmaceuticals to Participate in Upcoming May 2024 Conferences
07:30am, Monday, 29'th Apr 2024
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events: 2024 RBC Capital Marke
Arrowhead Pharmaceuticals to Host 2024 Summer Series of R&D Webinars
07:30am, Friday, 26'th Apr 2024
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced its plan to host a 2024 Summer Series of R&D webinars that highlight multiple clinical stage
Arrowhead Pharmaceuticals to Webcast Fiscal 2024 Second Quarter Results
04:01pm, Wednesday, 24'th Apr 2024
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on May 9, 2024, at 4:30 p.m. ET to discuss i
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-CFB for Treatment of Complement Mediated Kidney Disease
07:30am, Wednesday, 24'th Apr 2024
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced today that it has dosed the first subjects in a Phase 1/2a clinical trial (NCT06209177) of ARO-CFB
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today presented final data from the double-blind treatment period of its Phase 2 SHASTA-2 study of investiga
The 7 Most Undervalued Russell 2000 Stocks to Buy in April 2024
04:30pm, Friday, 05'th Apr 2024
It may not be much, but the Russell 2000 Index (RUT) is up 7% in 2024. The index still sits about 20% below the all-time high it reached in November 2021.
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
04:30pm, Monday, 01'st Apr 2024
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that as an inducement to entering into employment with the Company, on March 30, 2024, the C
7 Biotech Stocks to Buy as Sector Rotation Ramps Up
02:25pm, Wednesday, 13'th Mar 2024
While the technology sector has been enjoying ridiculous returns, it's inevitable that a slowdown (or even a correction) may materialize, which brings to the table biotech stocks. This is just as inno
The 3 Most Undervalued Russell 2000 Stocks to Buy in March 2024
06:53pm, Monday, 11'th Mar 2024
After closing out 2023 with a 15.1% gain, the Russell 2000 looks even better this year in the new year. In fact, since Jan. 2, the index is up about 4% year to date, and could push even higher, taking
